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To the Editor 
E-cigarettes are increasingly used, but their health effects remain unclear. The primary 
ingredients of e-cigarette liquid, propylene glycol and flavoring chemicals (e.g. diacetyl or 
diketone), are respiratory irritants and harmful to the lungs.1 Well-documented respiratory 
toxicants such as particulate matters, volatile organic compounds and metals were found in e-
cigarette aerosol although in lower concentrations than conventional cigarettes.2 Short-term 
adverse effects of airway resistance and inflammation have been observed in adults but null 
associations were also reported.3 Children are particularly vulnerable to respiratory pollutants yet 
no study has evaluated the respiratory effects of e-cigarettes in children. We assessed the 
association between e-cigarette use and respiratory symptoms in Chinese adolescents in Hong 
Kong. 
 
Methods 
During 2012/13, we surveyed Secondary 1 (US Grade 7, typically aged 12) to Secondary 6 
students from 75 randomly selected schools using an anonymous questionnaire based on the 
Global Youth Tobacco Survey.4 An invitation letter was sent to parents, and student participation 
was voluntary. Ethics approval was granted by a local institutional review board. A total of 
45128 students (94.5% of all invited) were available for analysis after data cleaning. Smoking 
status was defined as never-smoking, experimental smoking (smoked once or a few times), ex-
smoking (smoking in the past but not now) and current smoking (smoked on ≥1 day in the past 
30 days). E-cigarette use in the past 30 days (yes/no), respiratory symptoms (cough or phlegm) 
for 3 consecutive months in the past 12 months (yes/no), socio-demographic characteristics (sex, 
age, perceived family affluence) and secondhand smoke exposure were recorded. We weighted 
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descriptive data by sex, age and grade distribution of the corresponding general population. 
Adjusted odds ratios (AORs) of respiratory symptoms due to e-cigarette use were calculated 
using logistic regression (Stata 13.0; Stata corporation, College Station, TX, USA) for all 
students and by smoking status adjusting for socio-demographic characteristics, secondhand 
tobacco smoke exposure, school clustering effects and where appropriate, smoking status. 
 
Results 
The mean age was 14.6 ±1.9 years, and 51.1% were boys. Only 1.1% (95% confidence interval 
(CI) 1.0-1.2) of all students, 0.1% of never-smokers, 2.0% of experimenters, 9.6% of ex-smokers 
and 9.6% of current smokers had used e-cigarettes in the past 30 days. Respiratory symptoms 
were reported by 18.8% of all students, 17.7% of never-smokers, 25.8% of ever-smokers, 21.7% 
of experimenters, 27.2% of ex-smokers and 34.3% of current smokers. Figure 1 shows higher 
prevalence of respiratory symptoms in e-cigarette users regardless of smoking status. Overall, e-
cigarette use was significantly associated with respiratory symptoms (AOR 1.28, 95% CI 1.06-
1.56) (Table 1). The corresponding AORs (95% CI) were 2.06 (1.24-3.42) in never-smokers, 
1.39 (1.14-1.70) in ever-smokers and 1.40 (1.02-1.91) in ex-smokers. Positive but non-
significant associations were observed in experimenters (AOR 1.09, 95% CI 0.66-1.80) and 
current smokers (AOR 1.15, 95% CI 0.81-1.62). 
 
Comment 
We presented the first evidence of an association between e-cigarette use and respiratory 
symptoms in never and ever smoking adolescents, which were consistent with findings from 
other laboratory and adult studies on short-term adverse respiratory functions.3 Similar ORs 
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between crude and adjusted models suggested the association was unlikely due to confounding 
effects and e-cigarette use may independently predict respiratory symptoms. Respiratory 
symptoms are a simple and useful outcome to demonstrate the short-term health effect of e-
cigarette use while long-term effects are being studied. Nicotine-containing e-cigarettes are 
banned in Hong Kong but nicotine free e-cigarettes are not regulated and available from the 
Internet and retail stores. The strong association of respiratory symptoms with e-cigarettes 
observed in never smokers (AOR 2.06) is comparable to that found in adolescent occasional 
smokers (AOR 1.72).5 This finding, together with the potential of e-cigarettes becoming a 
gateway for conventional cigarettes,6 supported the World Health Organization’s 
recommendation on regulating e-cigarette use particularly in children.7 
 
(613 words) 
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Figure 1. Higher prevalence of respiratory symptoms in e-cigarette users than non-user across 
different smoking status 
 
χ2P is <0.001 for all students, <0.01 for never smokers, 0.01 for ever-smokers, 0.69 for 
experimenters, 0.04 for ex-smokers and 0.40 for current smokers. 
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Table 1. Associations of e-cigarettes use with respiratory symptoms by smoking status 
 N 
Respiratory symptoms (%) OR (95% CI) 
No e-cig E-cig Crudea Adjustedb 
All 44662 19.4 33.9 2.13 (1.82-2.48)*** 1.28 (1.06-1.56)*c 
Never smokers 36915 17.9 31.3 2.09 (1.27-3.44)** 2.06 (1.24-3.42)** 
Ever-smokers 7048 26.8 34.7 1.45 (1.19-1.78)** 1.39 (1.14-1.70)** 
Experimenters 3576 23.0 25.0 1.12 (0.67-1.87) 1.09 (0.66-1.80) 
Ex-smokers 1812 28.2 36.4 1.46 (1.07-2.00)* 1.40 (1.02-1.91)* 
Current smokers 1660 34.3 37.6 1.15 (0.82-1.62) 1.15 (0.81-1.62) 
aAdjusting for school clustering effects. 
bAdjusting for sex, age, perceived family affluence, secondhand smoke exposure and school 
clustering effects. 
cAdditionally adjusted for smoking status. 
*P<0.05; **P<0.01, ***P<0.001 
